Show & Tell #1: Head & Neck
Dr Alexander Lin, Medical Director at Penn Medicine's Roberts Proton Therapy Center...
Dr Alexander Lin, Medical Director at Penn Medicine's Roberts Proton Therapy Center...
This study compared work outcomes in patients with stage II-IVB squamous cell oropharyngeal cancer (OPC), randomized to intensity-modulated proton (IMPT) versus...
This study used clinicopathologic factors to match 25 patients with OPC who received IMPT and 25 patients with OPC treated with IMRT. Process maps were created...
This study conducted a retrospective propensity score matching analysis (1:1) of 80 NPC patients treated with IMPT and VMAT. At a median follow-up time of 24.1...
Based on the SEER database, this study reported that for Medicare beneficiaries with a first-time diagnosis of prostate cancer, the utilization of IMRT, proton...
Using collimation can sharpen the penumbra towards surrounding normal tissue in the low energy region of the proton beam, this study from Japan thus examined...
Published in JCO (Journal of Clinical Oncology), this randomized trial compared total toxicity burden (TTB) and progression-free survival (PFS) between PBT and...